These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 21931056)
1. High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome. Nakajima S; Watanabe H; Tohyama M; Sugita K; Iijima M; Hashimoto K; Tokura Y; Nishimura Y; Doi H; Tanioka M; Miyachi Y; Kabashima K Arch Dermatol; 2011 Sep; 147(9):1110-2. PubMed ID: 21931056 [No Abstract] [Full Text] [Related]
2. Toxic epidermal necrolysis in Stevens--Johnson syndrome. Assaad D; From L; Ricciatti D; Shapero H Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383 [TBL] [Abstract][Full Text] [Related]
3. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis. Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517 [TBL] [Abstract][Full Text] [Related]
5. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome. Fritsch P Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404 [No Abstract] [Full Text] [Related]
20. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases. Lee HY; Tey HL; Pang SM; Thirumoorthy T Lupus; 2011 May; 20(6):647-52. PubMed ID: 21148602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]